Article

Live Broadcast to Explore a Treatment Option for EGFR Exon20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer

In an upcoming live broadcast, Dr. Mark Socinski and Dr. Erminia Massarelli will discuss EGFR Exon20 insertion-positive non-small cell lung cancer and take a deeper look at current guideline-recommended testing. They will also talk about the safety and efficacy of a new option in patients previously treated with platinum-based chemotherapy. Additionally, they will discuss the implications of the data through a live question and answer session.

To obtain expert perspective and learn about how these results may affect your patients and your practice, watch the live broadcast on November 16th at 7PM ET or 9PM ET or November 17th at 12PM ET. To register for the event, visit https://studio.mjhassoc.com/reach/takedaonclivebroadcast.

USO-NON-0332 10/21

Related Videos
Dr Cascone on Evaluating Neoadjuvant Durvalumab-Based Regimens in Resectable NSCLC
FRCSI, FRCSEd, medical director, Thoracic Cancer Program, and associate executive director, AdventHealth Cancer Institute
Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine
Russell Hales, MD, director, Thoracic Oncology Multidisciplinary Program, associate professor, clinical radiation oncology and molecular radiation sciences, and director, thoracic multidisciplinary clinic, John Hopkins University School of Medicine
Estelamari Rodriguez, MD, MPH, associate director, Community Outreach – Thoracic Oncology, Sylvester Comprehensive Cancer Center
Misty D. Shields, MD, PhD, assistant professor, clinical medicine, Department of Medicine, Division of Hematology/Oncology, Indiana University (IU) School of Medicine; and associate member, Experimental and Developmental Therapeutics, IU Melvin and Bren Simon Comprehensive Cancer Center
Corey J. Langer, MD, director, Thoracic Oncology, Penn Medicine; and professor, medicine (hematology-oncology), the Hospital of the University of Pennsylvania, Perelman School of Medicine
Alexander I. Spira MD, PhD, FACP, FASCO
Hidehito Horinouchi, MD, PhD